nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—BCL2—malignant glioma	0.37	0.605	CbGaD
Docetaxel—EGFR—malignant glioma	0.242	0.395	CbGaD
Docetaxel—Effusion—Carmustine—malignant glioma	0.00784	0.0621	CcSEcCtD
Docetaxel—MAP2—telencephalic ventricle—malignant glioma	0.00425	0.048	CbGeAlD
Docetaxel—Metastatic neoplasm—Temozolomide—malignant glioma	0.00414	0.0328	CcSEcCtD
Docetaxel—Myelodysplastic syndrome—Temozolomide—malignant glioma	0.00396	0.0313	CcSEcCtD
Docetaxel—GHRHR—brainstem—malignant glioma	0.00373	0.0421	CbGeAlD
Docetaxel—KIF11—embryo—malignant glioma	0.00346	0.039	CbGeAlD
Docetaxel—Acute leukaemia—Carmustine—malignant glioma	0.00288	0.0228	CcSEcCtD
Docetaxel—Acute leukaemia—Temozolomide—malignant glioma	0.00278	0.022	CcSEcCtD
Docetaxel—Paclitaxel—BCL2—malignant glioma	0.00268	1	CrCbGaD
Docetaxel—GHRHR—central nervous system—malignant glioma	0.00188	0.0212	CbGeAlD
Docetaxel—Pulmonary fibrosis—Carmustine—malignant glioma	0.00187	0.0148	CcSEcCtD
Docetaxel—GHRHR—cerebellum—malignant glioma	0.00184	0.0207	CbGeAlD
Docetaxel—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00181	0.0143	CcSEcCtD
Docetaxel—MAPT—retina—malignant glioma	0.00179	0.0202	CbGeAlD
Docetaxel—Myelosuppression—Carmustine—malignant glioma	0.00175	0.0139	CcSEcCtD
Docetaxel—Myelosuppression—Temozolomide—malignant glioma	0.00169	0.0134	CcSEcCtD
Docetaxel—MAPT—telencephalon—malignant glioma	0.00165	0.0186	CbGeAlD
Docetaxel—Interstitial pneumonia—Temozolomide—malignant glioma	0.00164	0.013	CcSEcCtD
Docetaxel—MAP4—embryo—malignant glioma	0.0016	0.018	CbGeAlD
Docetaxel—Lymphopenia—Temozolomide—malignant glioma	0.00155	0.0123	CcSEcCtD
Docetaxel—GHRHR—brain—malignant glioma	0.00149	0.0168	CbGeAlD
Docetaxel—MAP4—brainstem—malignant glioma	0.00146	0.0165	CbGeAlD
Docetaxel—MAP4—retina—malignant glioma	0.00141	0.0159	CbGeAlD
Docetaxel—Skin hyperpigmentation—Carmustine—malignant glioma	0.00138	0.0109	CcSEcCtD
Docetaxel—Febrile neutropenia—Carmustine—malignant glioma	0.00137	0.0108	CcSEcCtD
Docetaxel—Haemorrhoids—Temozolomide—malignant glioma	0.00135	0.0107	CcSEcCtD
Docetaxel—Febrile neutropenia—Temozolomide—malignant glioma	0.00132	0.0105	CcSEcCtD
Docetaxel—Deep vein thrombosis—Temozolomide—malignant glioma	0.00131	0.0103	CcSEcCtD
Docetaxel—MAP4—telencephalon—malignant glioma	0.0013	0.0146	CbGeAlD
Docetaxel—MAPT—medulla oblongata—malignant glioma	0.0013	0.0146	CbGeAlD
Docetaxel—Oral candidiasis—Carmustine—malignant glioma	0.00129	0.0102	CcSEcCtD
Docetaxel—KIF11—brain—malignant glioma	0.00127	0.0143	CbGeAlD
Docetaxel—MAP2—embryo—malignant glioma	0.00126	0.0142	CbGeAlD
Docetaxel—Oral candidiasis—Temozolomide—malignant glioma	0.00125	0.0099	CcSEcCtD
Docetaxel—Embolism—Temozolomide—malignant glioma	0.00124	0.0098	CcSEcCtD
Docetaxel—Cyst—Carmustine—malignant glioma	0.00123	0.00974	CcSEcCtD
Docetaxel—Parosmia—Temozolomide—malignant glioma	0.00122	0.0097	CcSEcCtD
Docetaxel—MAPT—midbrain—malignant glioma	0.00119	0.0134	CbGeAlD
Docetaxel—Burning sensation—Carmustine—malignant glioma	0.00118	0.00937	CcSEcCtD
Docetaxel—BCL2—telencephalon—malignant glioma	0.00118	0.0133	CbGeAlD
Docetaxel—EGFR—telencephalon—malignant glioma	0.00117	0.0131	CbGeAlD
Docetaxel—Interstitial lung disease—Carmustine—malignant glioma	0.00116	0.0092	CcSEcCtD
Docetaxel—MAPT—spinal cord—malignant glioma	0.00116	0.013	CbGeAlD
Docetaxel—MAP2—brainstem—malignant glioma	0.00115	0.013	CbGeAlD
Docetaxel—Interstitial lung disease—Temozolomide—malignant glioma	0.00112	0.00889	CcSEcCtD
Docetaxel—MAP2—retina—malignant glioma	0.00111	0.0125	CbGeAlD
Docetaxel—Scotoma—Carmustine—malignant glioma	0.00108	0.00857	CcSEcCtD
Docetaxel—TUBB8—central nervous system—malignant glioma	0.00108	0.0122	CbGeAlD
Docetaxel—Hepatotoxicity—Carmustine—malignant glioma	0.00106	0.00843	CcSEcCtD
Docetaxel—Necrosis—Carmustine—malignant glioma	0.00105	0.00829	CcSEcCtD
Docetaxel—Scotoma—Temozolomide—malignant glioma	0.00105	0.00828	CcSEcCtD
Docetaxel—Hepatotoxicity—Temozolomide—malignant glioma	0.00103	0.00815	CcSEcCtD
Docetaxel—MAP2—telencephalon—malignant glioma	0.00102	0.0115	CbGeAlD
Docetaxel—Otitis media—Temozolomide—malignant glioma	0.00102	0.00808	CcSEcCtD
Docetaxel—MAP4—medulla oblongata—malignant glioma	0.00102	0.0115	CbGeAlD
Docetaxel—Rigors—Temozolomide—malignant glioma	0.000973	0.00771	CcSEcCtD
Docetaxel—TUBB4A—embryo—malignant glioma	0.000971	0.0109	CbGeAlD
Docetaxel—Extravasation—Carmustine—malignant glioma	0.000942	0.00746	CcSEcCtD
Docetaxel—MAP4—midbrain—malignant glioma	0.000932	0.0105	CbGeAlD
Docetaxel—MAPT—cerebellum—malignant glioma	0.000917	0.0103	CbGeAlD
Docetaxel—MAP4—spinal cord—malignant glioma	0.000909	0.0102	CbGeAlD
Docetaxel—Amenorrhoea—Temozolomide—malignant glioma	0.000904	0.00716	CcSEcCtD
Docetaxel—TUBB4A—brainstem—malignant glioma	0.00089	0.01	CbGeAlD
Docetaxel—Drug interaction—Carmustine—malignant glioma	0.000886	0.00702	CcSEcCtD
Docetaxel—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000874	0.00692	CcSEcCtD
Docetaxel—TUBB4A—retina—malignant glioma	0.000858	0.00968	CbGeAlD
Docetaxel—TUBB8—brain—malignant glioma	0.000858	0.00967	CbGeAlD
Docetaxel—Hearing impaired—Temozolomide—malignant glioma	0.000835	0.00661	CcSEcCtD
Docetaxel—TUBB2B—retina—malignant glioma	0.00083	0.00935	CbGeAlD
Docetaxel—Pulmonary embolism—Carmustine—malignant glioma	0.000822	0.00651	CcSEcCtD
Docetaxel—Injection site reaction—Carmustine—malignant glioma	0.000817	0.00647	CcSEcCtD
Docetaxel—Respiratory failure—Temozolomide—malignant glioma	0.000809	0.00641	CcSEcCtD
Docetaxel—MAP2—medulla oblongata—malignant glioma	0.000803	0.00905	CbGeAlD
Docetaxel—Pulmonary embolism—Temozolomide—malignant glioma	0.000795	0.00629	CcSEcCtD
Docetaxel—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000795	0.00629	CcSEcCtD
Docetaxel—TUBB4A—telencephalon—malignant glioma	0.00079	0.0089	CbGeAlD
Docetaxel—Skin exfoliation—Carmustine—malignant glioma	0.000785	0.00621	CcSEcCtD
Docetaxel—Candida infection—Carmustine—malignant glioma	0.000785	0.00621	CcSEcCtD
Docetaxel—Neuropathy—Carmustine—malignant glioma	0.000772	0.00611	CcSEcCtD
Docetaxel—Influenza like illness—Temozolomide—malignant glioma	0.000772	0.00611	CcSEcCtD
Docetaxel—TUBB2B—telencephalon—malignant glioma	0.000763	0.0086	CbGeAlD
Docetaxel—Skin exfoliation—Temozolomide—malignant glioma	0.000759	0.00601	CcSEcCtD
Docetaxel—Candida infection—Temozolomide—malignant glioma	0.000759	0.00601	CcSEcCtD
Docetaxel—TUBB4B—embryo—malignant glioma	0.000757	0.00854	CbGeAlD
Docetaxel—Neuropathy—Temozolomide—malignant glioma	0.000746	0.00591	CcSEcCtD
Docetaxel—MAPT—brain—malignant glioma	0.000745	0.0084	CbGeAlD
Docetaxel—Neoplasm—Carmustine—malignant glioma	0.000743	0.00589	CcSEcCtD
Docetaxel—TUBB3—central nervous system—malignant glioma	0.000737	0.00831	CbGeAlD
Docetaxel—MAP4—central nervous system—malignant glioma	0.000737	0.00831	CbGeAlD
Docetaxel—MAP2—midbrain—malignant glioma	0.000734	0.00827	CbGeAlD
Docetaxel—TUBB—telencephalon—malignant glioma	0.000722	0.00814	CbGeAlD
Docetaxel—TUBB1—central nervous system—malignant glioma	0.000721	0.00813	CbGeAlD
Docetaxel—TUBB3—cerebellum—malignant glioma	0.000721	0.00813	CbGeAlD
Docetaxel—MAP4—cerebellum—malignant glioma	0.000721	0.00813	CbGeAlD
Docetaxel—Neoplasm—Temozolomide—malignant glioma	0.000718	0.00569	CcSEcCtD
Docetaxel—TUBB2A—telencephalon—malignant glioma	0.000718	0.0081	CbGeAlD
Docetaxel—MAP2—spinal cord—malignant glioma	0.000716	0.00807	CbGeAlD
Docetaxel—Sepsis—Carmustine—malignant glioma	0.000713	0.00565	CcSEcCtD
Docetaxel—Phlebitis—Carmustine—malignant glioma	0.000693	0.00548	CcSEcCtD
Docetaxel—Thrombophlebitis—Carmustine—malignant glioma	0.000689	0.00546	CcSEcCtD
Docetaxel—Swelling—Carmustine—malignant glioma	0.000676	0.00536	CcSEcCtD
Docetaxel—BCL2—central nervous system—malignant glioma	0.00067	0.00756	CbGeAlD
Docetaxel—TUBB4B—retina—malignant glioma	0.000669	0.00755	CbGeAlD
Docetaxel—Thrombophlebitis—Temozolomide—malignant glioma	0.000666	0.00528	CcSEcCtD
Docetaxel—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000663	0.00525	CcSEcCtD
Docetaxel—EGFR—cerebellum—malignant glioma	0.000647	0.0073	CbGeAlD
Docetaxel—Deafness—Temozolomide—malignant glioma	0.000645	0.0051	CcSEcCtD
Docetaxel—Hepatic failure—Temozolomide—malignant glioma	0.000642	0.00508	CcSEcCtD
Docetaxel—TUBB4A—medulla oblongata—malignant glioma	0.00062	0.00699	CbGeAlD
Docetaxel—ABCC10—telencephalon—malignant glioma	0.00062	0.00699	CbGeAlD
Docetaxel—Hot flush—Temozolomide—malignant glioma	0.000617	0.00488	CcSEcCtD
Docetaxel—TUBB4B—telencephalon—malignant glioma	0.000616	0.00694	CbGeAlD
Docetaxel—Menopausal symptoms—Temozolomide—malignant glioma	0.000611	0.00484	CcSEcCtD
Docetaxel—TUBB2B—medulla oblongata—malignant glioma	0.0006	0.00676	CbGeAlD
Docetaxel—Hyponatraemia—Carmustine—malignant glioma	0.000599	0.00474	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000597	0.00473	CcSEcCtD
Docetaxel—TUBB3—brain—malignant glioma	0.000585	0.0066	CbGeAlD
Docetaxel—MAP4—brain—malignant glioma	0.000585	0.0066	CbGeAlD
Docetaxel—MAP2—central nervous system—malignant glioma	0.000581	0.00655	CbGeAlD
Docetaxel—TUBB1—brain—malignant glioma	0.000572	0.00645	CbGeAlD
Docetaxel—MAP2—cerebellum—malignant glioma	0.000568	0.0064	CbGeAlD
Docetaxel—TUBB—medulla oblongata—malignant glioma	0.000567	0.0064	CbGeAlD
Docetaxel—TUBB4A—midbrain—malignant glioma	0.000567	0.00639	CbGeAlD
Docetaxel—TUBB2A—medulla oblongata—malignant glioma	0.000564	0.00636	CbGeAlD
Docetaxel—Ataxia—Carmustine—malignant glioma	0.000561	0.00444	CcSEcCtD
Docetaxel—TUBB6—medulla oblongata—malignant glioma	0.000557	0.00628	CbGeAlD
Docetaxel—TUBB4A—spinal cord—malignant glioma	0.000553	0.00624	CbGeAlD
Docetaxel—Liver function test abnormal—Carmustine—malignant glioma	0.000551	0.00436	CcSEcCtD
Docetaxel—TUBB2B—midbrain—malignant glioma	0.000548	0.00618	CbGeAlD
Docetaxel—Ataxia—Temozolomide—malignant glioma	0.000542	0.00429	CcSEcCtD
Docetaxel—Dehydration—Temozolomide—malignant glioma	0.000536	0.00425	CcSEcCtD
Docetaxel—TUBB2B—spinal cord—malignant glioma	0.000535	0.00603	CbGeAlD
Docetaxel—BCL2—brain—malignant glioma	0.000532	0.006	CbGeAlD
Docetaxel—Dry skin—Temozolomide—malignant glioma	0.000529	0.00419	CcSEcCtD
Docetaxel—EGFR—brain—malignant glioma	0.000526	0.00593	CbGeAlD
Docetaxel—Breast disorder—Temozolomide—malignant glioma	0.000521	0.00413	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000519	0.00411	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000519	0.00411	CcSEcCtD
Docetaxel—TUBB—midbrain—malignant glioma	0.000519	0.00585	CbGeAlD
Docetaxel—TUBB2A—midbrain—malignant glioma	0.000516	0.00582	CbGeAlD
Docetaxel—Dysphagia—Carmustine—malignant glioma	0.000516	0.00408	CcSEcCtD
Docetaxel—TUBB6—midbrain—malignant glioma	0.000509	0.00574	CbGeAlD
Docetaxel—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000509	0.00403	CcSEcCtD
Docetaxel—TUBB—spinal cord—malignant glioma	0.000506	0.0057	CbGeAlD
Docetaxel—TUBB2A—spinal cord—malignant glioma	0.000503	0.00567	CbGeAlD
Docetaxel—Dysphagia—Temozolomide—malignant glioma	0.000498	0.00395	CcSEcCtD
Docetaxel—TUBB6—spinal cord—malignant glioma	0.000496	0.0056	CbGeAlD
Docetaxel—Pancytopenia—Carmustine—malignant glioma	0.00049	0.00388	CcSEcCtD
Docetaxel—CYP1B1—telencephalon—malignant glioma	0.000488	0.0055	CbGeAlD
Docetaxel—ABCC10—medulla oblongata—malignant glioma	0.000487	0.00549	CbGeAlD
Docetaxel—TUBB4B—medulla oblongata—malignant glioma	0.000484	0.00546	CbGeAlD
Docetaxel—Neutropenia—Carmustine—malignant glioma	0.000482	0.00382	CcSEcCtD
Docetaxel—Pancytopenia—Temozolomide—malignant glioma	0.000473	0.00375	CcSEcCtD
Docetaxel—Neutropenia—Temozolomide—malignant glioma	0.000466	0.00369	CcSEcCtD
Docetaxel—Pneumonia—Carmustine—malignant glioma	0.000463	0.00366	CcSEcCtD
Docetaxel—MAP2—brain—malignant glioma	0.000461	0.0052	CbGeAlD
Docetaxel—Weight increased—Temozolomide—malignant glioma	0.000454	0.00359	CcSEcCtD
Docetaxel—Renal failure—Carmustine—malignant glioma	0.000452	0.00358	CcSEcCtD
Docetaxel—Weight decreased—Temozolomide—malignant glioma	0.000451	0.00357	CcSEcCtD
Docetaxel—Neuropathy peripheral—Carmustine—malignant glioma	0.000451	0.00357	CcSEcCtD
Docetaxel—TUBB4A—central nervous system—malignant glioma	0.000449	0.00506	CbGeAlD
Docetaxel—Stomatitis—Carmustine—malignant glioma	0.000448	0.00355	CcSEcCtD
Docetaxel—Pneumonia—Temozolomide—malignant glioma	0.000447	0.00354	CcSEcCtD
Docetaxel—ABCC10—midbrain—malignant glioma	0.000445	0.00502	CbGeAlD
Docetaxel—Infestation—Temozolomide—malignant glioma	0.000444	0.00352	CcSEcCtD
Docetaxel—Infestation NOS—Temozolomide—malignant glioma	0.000444	0.00352	CcSEcCtD
Docetaxel—TUBB4B—midbrain—malignant glioma	0.000442	0.00499	CbGeAlD
Docetaxel—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000441	0.00349	CcSEcCtD
Docetaxel—ABCC1—telencephalon—malignant glioma	0.000439	0.00495	CbGeAlD
Docetaxel—TUBB4A—cerebellum—malignant glioma	0.000439	0.00495	CbGeAlD
Docetaxel—Neuropathy peripheral—Temozolomide—malignant glioma	0.000436	0.00345	CcSEcCtD
Docetaxel—ABCC10—spinal cord—malignant glioma	0.000435	0.0049	CbGeAlD
Docetaxel—TUBB2B—central nervous system—malignant glioma	0.000434	0.00489	CbGeAlD
Docetaxel—Stomatitis—Temozolomide—malignant glioma	0.000433	0.00343	CcSEcCtD
Docetaxel—TUBB4B—spinal cord—malignant glioma	0.000431	0.00486	CbGeAlD
Docetaxel—TUBB2B—cerebellum—malignant glioma	0.000424	0.00478	CbGeAlD
Docetaxel—Hepatobiliary disease—Temozolomide—malignant glioma	0.00042	0.00333	CcSEcCtD
Docetaxel—Haemoglobin—Carmustine—malignant glioma	0.000415	0.00329	CcSEcCtD
Docetaxel—Haemorrhage—Carmustine—malignant glioma	0.000413	0.00327	CcSEcCtD
Docetaxel—Hypoaesthesia—Carmustine—malignant glioma	0.000411	0.00325	CcSEcCtD
Docetaxel—TUBB2A—central nervous system—malignant glioma	0.000408	0.0046	CbGeAlD
Docetaxel—Oedema peripheral—Carmustine—malignant glioma	0.000407	0.00322	CcSEcCtD
Docetaxel—Connective tissue disorder—Carmustine—malignant glioma	0.000406	0.00321	CcSEcCtD
Docetaxel—TUBB6—central nervous system—malignant glioma	0.000403	0.00454	CbGeAlD
Docetaxel—TUBB—cerebellum—malignant glioma	0.000401	0.00452	CbGeAlD
Docetaxel—Haemoglobin—Temozolomide—malignant glioma	0.000401	0.00318	CcSEcCtD
Docetaxel—TUBB2A—cerebellum—malignant glioma	0.000399	0.0045	CbGeAlD
Docetaxel—Hepatitis—Temozolomide—malignant glioma	0.000399	0.00316	CcSEcCtD
Docetaxel—Haemorrhage—Temozolomide—malignant glioma	0.000399	0.00316	CcSEcCtD
Docetaxel—SLC22A7—brain—malignant glioma	0.000399	0.00449	CbGeAlD
Docetaxel—Visual impairment—Carmustine—malignant glioma	0.000398	0.00315	CcSEcCtD
Docetaxel—Hypoaesthesia—Temozolomide—malignant glioma	0.000397	0.00314	CcSEcCtD
Docetaxel—Pharyngitis—Temozolomide—malignant glioma	0.000396	0.00314	CcSEcCtD
Docetaxel—Urinary tract disorder—Temozolomide—malignant glioma	0.000394	0.00312	CcSEcCtD
Docetaxel—TUBB6—cerebellum—malignant glioma	0.000394	0.00444	CbGeAlD
Docetaxel—Oedema peripheral—Temozolomide—malignant glioma	0.000393	0.00311	CcSEcCtD
Docetaxel—Connective tissue disorder—Temozolomide—malignant glioma	0.000392	0.0031	CcSEcCtD
Docetaxel—Urethral disorder—Temozolomide—malignant glioma	0.000391	0.0031	CcSEcCtD
Docetaxel—Eye disorder—Carmustine—malignant glioma	0.000386	0.00305	CcSEcCtD
Docetaxel—Visual impairment—Temozolomide—malignant glioma	0.000384	0.00304	CcSEcCtD
Docetaxel—Flushing—Carmustine—malignant glioma	0.000383	0.00303	CcSEcCtD
Docetaxel—Erythema multiforme—Temozolomide—malignant glioma	0.000377	0.00299	CcSEcCtD
Docetaxel—Eye disorder—Temozolomide—malignant glioma	0.000373	0.00295	CcSEcCtD
Docetaxel—Cardiac disorder—Temozolomide—malignant glioma	0.00037	0.00293	CcSEcCtD
Docetaxel—Flushing—Temozolomide—malignant glioma	0.00037	0.00293	CcSEcCtD
Docetaxel—ABCB1—blood vessel—malignant glioma	0.000369	0.00416	CbGeAlD
Docetaxel—Arrhythmia—Carmustine—malignant glioma	0.000369	0.00292	CcSEcCtD
Docetaxel—Alopecia—Carmustine—malignant glioma	0.000365	0.00289	CcSEcCtD
Docetaxel—ABCG2—telencephalon—malignant glioma	0.000363	0.0041	CbGeAlD
Docetaxel—Angiopathy—Temozolomide—malignant glioma	0.000362	0.00287	CcSEcCtD
Docetaxel—Mental disorder—Carmustine—malignant glioma	0.000362	0.00286	CcSEcCtD
Docetaxel—Immune system disorder—Temozolomide—malignant glioma	0.00036	0.00285	CcSEcCtD
Docetaxel—Mediastinal disorder—Temozolomide—malignant glioma	0.00036	0.00285	CcSEcCtD
Docetaxel—Erythema—Carmustine—malignant glioma	0.000359	0.00285	CcSEcCtD
Docetaxel—Malnutrition—Carmustine—malignant glioma	0.000359	0.00285	CcSEcCtD
Docetaxel—Chills—Temozolomide—malignant glioma	0.000358	0.00283	CcSEcCtD
Docetaxel—TUBB4A—brain—malignant glioma	0.000356	0.00402	CbGeAlD
Docetaxel—Alopecia—Temozolomide—malignant glioma	0.000353	0.00279	CcSEcCtD
Docetaxel—TUBB4B—central nervous system—malignant glioma	0.00035	0.00395	CbGeAlD
Docetaxel—Mental disorder—Temozolomide—malignant glioma	0.00035	0.00277	CcSEcCtD
Docetaxel—Back pain—Carmustine—malignant glioma	0.000348	0.00275	CcSEcCtD
Docetaxel—Erythema—Temozolomide—malignant glioma	0.000347	0.00275	CcSEcCtD
Docetaxel—Malnutrition—Temozolomide—malignant glioma	0.000347	0.00275	CcSEcCtD
Docetaxel—ABCC10—cerebellum—malignant glioma	0.000345	0.00389	CbGeAlD
Docetaxel—TUBB2B—brain—malignant glioma	0.000344	0.00388	CbGeAlD
Docetaxel—TUBB4B—cerebellum—malignant glioma	0.000342	0.00386	CbGeAlD
Docetaxel—Dysgeusia—Temozolomide—malignant glioma	0.00034	0.00269	CcSEcCtD
Docetaxel—Back pain—Temozolomide—malignant glioma	0.000336	0.00266	CcSEcCtD
Docetaxel—Anaemia—Carmustine—malignant glioma	0.000332	0.00263	CcSEcCtD
Docetaxel—TUBB—brain—malignant glioma	0.000326	0.00367	CbGeAlD
Docetaxel—TUBB2A—brain—malignant glioma	0.000324	0.00365	CbGeAlD
Docetaxel—Leukopenia—Carmustine—malignant glioma	0.000322	0.00255	CcSEcCtD
Docetaxel—Anaemia—Temozolomide—malignant glioma	0.000321	0.00254	CcSEcCtD
Docetaxel—TUBB6—brain—malignant glioma	0.00032	0.0036	CbGeAlD
Docetaxel—Convulsion—Carmustine—malignant glioma	0.000311	0.00247	CcSEcCtD
Docetaxel—Leukopenia—Temozolomide—malignant glioma	0.000311	0.00246	CcSEcCtD
Docetaxel—Hypertension—Carmustine—malignant glioma	0.00031	0.00246	CcSEcCtD
Docetaxel—Palpitations—Temozolomide—malignant glioma	0.000307	0.00243	CcSEcCtD
Docetaxel—Chest pain—Carmustine—malignant glioma	0.000306	0.00242	CcSEcCtD
Docetaxel—Myalgia—Carmustine—malignant glioma	0.000306	0.00242	CcSEcCtD
Docetaxel—Cough—Temozolomide—malignant glioma	0.000303	0.0024	CcSEcCtD
Docetaxel—Convulsion—Temozolomide—malignant glioma	0.000301	0.00238	CcSEcCtD
Docetaxel—Hypertension—Temozolomide—malignant glioma	0.0003	0.00237	CcSEcCtD
Docetaxel—Confusional state—Carmustine—malignant glioma	0.000296	0.00234	CcSEcCtD
Docetaxel—Arthralgia—Temozolomide—malignant glioma	0.000296	0.00234	CcSEcCtD
Docetaxel—Myalgia—Temozolomide—malignant glioma	0.000296	0.00234	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000294	0.00233	CcSEcCtD
Docetaxel—Oedema—Carmustine—malignant glioma	0.000293	0.00232	CcSEcCtD
Docetaxel—Infection—Carmustine—malignant glioma	0.000291	0.00231	CcSEcCtD
Docetaxel—Dry mouth—Temozolomide—malignant glioma	0.000289	0.00229	CcSEcCtD
Docetaxel—Thrombocytopenia—Carmustine—malignant glioma	0.000287	0.00227	CcSEcCtD
Docetaxel—Tachycardia—Carmustine—malignant glioma	0.000286	0.00227	CcSEcCtD
Docetaxel—Confusional state—Temozolomide—malignant glioma	0.000286	0.00226	CcSEcCtD
Docetaxel—ABCG2—medulla oblongata—malignant glioma	0.000285	0.00322	CbGeAlD
Docetaxel—Anaphylactic shock—Temozolomide—malignant glioma	0.000283	0.00224	CcSEcCtD
Docetaxel—Oedema—Temozolomide—malignant glioma	0.000283	0.00224	CcSEcCtD
Docetaxel—Infection—Temozolomide—malignant glioma	0.000282	0.00223	CcSEcCtD
Docetaxel—ABCC10—brain—malignant glioma	0.00028	0.00316	CbGeAlD
Docetaxel—Anorexia—Carmustine—malignant glioma	0.00028	0.00221	CcSEcCtD
Docetaxel—Nervous system disorder—Temozolomide—malignant glioma	0.000278	0.0022	CcSEcCtD
Docetaxel—TUBB4B—brain—malignant glioma	0.000278	0.00313	CbGeAlD
Docetaxel—Thrombocytopenia—Temozolomide—malignant glioma	0.000278	0.0022	CcSEcCtD
Docetaxel—CYP1B1—central nervous system—malignant glioma	0.000277	0.00313	CbGeAlD
Docetaxel—Skin disorder—Temozolomide—malignant glioma	0.000275	0.00218	CcSEcCtD
Docetaxel—Hypotension—Carmustine—malignant glioma	0.000274	0.00217	CcSEcCtD
Docetaxel—CYP1B1—cerebellum—malignant glioma	0.000271	0.00306	CbGeAlD
Docetaxel—Anorexia—Temozolomide—malignant glioma	0.00027	0.00214	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000267	0.00212	CcSEcCtD
Docetaxel—Insomnia—Carmustine—malignant glioma	0.000265	0.0021	CcSEcCtD
Docetaxel—Paraesthesia—Carmustine—malignant glioma	0.000263	0.00209	CcSEcCtD
Docetaxel—Dyspnoea—Carmustine—malignant glioma	0.000262	0.00207	CcSEcCtD
Docetaxel—ABCG2—midbrain—malignant glioma	0.000261	0.00294	CbGeAlD
Docetaxel—Somnolence—Carmustine—malignant glioma	0.000261	0.00206	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000258	0.00204	CcSEcCtD
Docetaxel—Insomnia—Temozolomide—malignant glioma	0.000256	0.00203	CcSEcCtD
Docetaxel—Decreased appetite—Carmustine—malignant glioma	0.000255	0.00202	CcSEcCtD
Docetaxel—Paraesthesia—Temozolomide—malignant glioma	0.000255	0.00202	CcSEcCtD
Docetaxel—ABCG2—spinal cord—malignant glioma	0.000254	0.00287	CbGeAlD
Docetaxel—Gastrointestinal disorder—Carmustine—malignant glioma	0.000253	0.00201	CcSEcCtD
Docetaxel—Dyspnoea—Temozolomide—malignant glioma	0.000253	0.002	CcSEcCtD
Docetaxel—Somnolence—Temozolomide—malignant glioma	0.000252	0.002	CcSEcCtD
Docetaxel—Constipation—Carmustine—malignant glioma	0.000251	0.00199	CcSEcCtD
Docetaxel—Pain—Carmustine—malignant glioma	0.000251	0.00199	CcSEcCtD
Docetaxel—Dyspepsia—Temozolomide—malignant glioma	0.00025	0.00198	CcSEcCtD
Docetaxel—Decreased appetite—Temozolomide—malignant glioma	0.000246	0.00195	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000245	0.00194	CcSEcCtD
Docetaxel—Fatigue—Temozolomide—malignant glioma	0.000244	0.00193	CcSEcCtD
Docetaxel—ABCC1—cerebellum—malignant glioma	0.000244	0.00275	CbGeAlD
Docetaxel—Constipation—Temozolomide—malignant glioma	0.000242	0.00192	CcSEcCtD
Docetaxel—Pain—Temozolomide—malignant glioma	0.000242	0.00192	CcSEcCtD
Docetaxel—Feeling abnormal—Carmustine—malignant glioma	0.000242	0.00191	CcSEcCtD
Docetaxel—Gastrointestinal pain—Carmustine—malignant glioma	0.00024	0.0019	CcSEcCtD
Docetaxel—Feeling abnormal—Temozolomide—malignant glioma	0.000234	0.00185	CcSEcCtD
Docetaxel—Abdominal pain—Carmustine—malignant glioma	0.000232	0.00184	CcSEcCtD
Docetaxel—Body temperature increased—Carmustine—malignant glioma	0.000232	0.00184	CcSEcCtD
Docetaxel—Gastrointestinal pain—Temozolomide—malignant glioma	0.000232	0.00184	CcSEcCtD
Docetaxel—Body temperature increased—Temozolomide—malignant glioma	0.000224	0.00177	CcSEcCtD
Docetaxel—Abdominal pain—Temozolomide—malignant glioma	0.000224	0.00177	CcSEcCtD
Docetaxel—ABCB1—embryo—malignant glioma	0.00022	0.00248	CbGeAlD
Docetaxel—CYP1B1—brain—malignant glioma	0.00022	0.00248	CbGeAlD
Docetaxel—Hypersensitivity—Carmustine—malignant glioma	0.000216	0.00171	CcSEcCtD
Docetaxel—Asthenia—Carmustine—malignant glioma	0.00021	0.00167	CcSEcCtD
Docetaxel—Hypersensitivity—Temozolomide—malignant glioma	0.000209	0.00165	CcSEcCtD
Docetaxel—Asthenia—Temozolomide—malignant glioma	0.000203	0.00161	CcSEcCtD
Docetaxel—ABCG2—cerebellum—malignant glioma	0.000202	0.00227	CbGeAlD
Docetaxel—Diarrhoea—Carmustine—malignant glioma	0.000201	0.00159	CcSEcCtD
Docetaxel—Pruritus—Temozolomide—malignant glioma	0.000201	0.00159	CcSEcCtD
Docetaxel—ABCC1—brain—malignant glioma	0.000198	0.00223	CbGeAlD
Docetaxel—ABCB1—retina—malignant glioma	0.000195	0.0022	CbGeAlD
Docetaxel—Dizziness—Carmustine—malignant glioma	0.000194	0.00154	CcSEcCtD
Docetaxel—Diarrhoea—Temozolomide—malignant glioma	0.000194	0.00154	CcSEcCtD
Docetaxel—Dizziness—Temozolomide—malignant glioma	0.000187	0.00148	CcSEcCtD
Docetaxel—Vomiting—Carmustine—malignant glioma	0.000186	0.00148	CcSEcCtD
Docetaxel—Rash—Carmustine—malignant glioma	0.000185	0.00146	CcSEcCtD
Docetaxel—Dermatitis—Carmustine—malignant glioma	0.000185	0.00146	CcSEcCtD
Docetaxel—Headache—Carmustine—malignant glioma	0.000184	0.00145	CcSEcCtD
Docetaxel—Vomiting—Temozolomide—malignant glioma	0.00018	0.00143	CcSEcCtD
Docetaxel—ABCB1—telencephalon—malignant glioma	0.000179	0.00202	CbGeAlD
Docetaxel—Rash—Temozolomide—malignant glioma	0.000179	0.00142	CcSEcCtD
Docetaxel—Dermatitis—Temozolomide—malignant glioma	0.000179	0.00141	CcSEcCtD
Docetaxel—Headache—Temozolomide—malignant glioma	0.000178	0.00141	CcSEcCtD
Docetaxel—Nausea—Carmustine—malignant glioma	0.000174	0.00138	CcSEcCtD
Docetaxel—Nausea—Temozolomide—malignant glioma	0.000168	0.00133	CcSEcCtD
Docetaxel—ABCG2—brain—malignant glioma	0.000164	0.00185	CbGeAlD
Docetaxel—CYP3A4—central nervous system—malignant glioma	0.000144	0.00162	CbGeAlD
Docetaxel—ABCB1—medulla oblongata—malignant glioma	0.000141	0.00159	CbGeAlD
Docetaxel—ABCB1—midbrain—malignant glioma	0.000129	0.00145	CbGeAlD
Docetaxel—ABCB1—spinal cord—malignant glioma	0.000125	0.00141	CbGeAlD
Docetaxel—ABCB1—central nervous system—malignant glioma	0.000102	0.00115	CbGeAlD
Docetaxel—ABCB1—cerebellum—malignant glioma	9.95e-05	0.00112	CbGeAlD
Docetaxel—ABCB1—brain—malignant glioma	8.08e-05	0.000911	CbGeAlD
Docetaxel—ABCC1—Disease—CAV1—malignant glioma	6.15e-06	3.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PTPN11—malignant glioma	6.15e-06	3.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PDGFB—malignant glioma	6.12e-06	3.59e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NCOR1—malignant glioma	6.12e-06	3.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH2—malignant glioma	6.11e-06	3.59e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	6.11e-06	3.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGFR1—malignant glioma	6.09e-06	3.57e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTP1—malignant glioma	6.05e-06	3.55e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTP1—malignant glioma	6e-06	3.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HIF1A—malignant glioma	6e-06	3.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KNG1—malignant glioma	5.98e-06	3.51e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SPHK1—malignant glioma	5.96e-06	3.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BAD—malignant glioma	5.91e-06	3.47e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CAT—malignant glioma	5.89e-06	3.46e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS1—malignant glioma	5.86e-06	3.44e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CAT—malignant glioma	5.84e-06	3.43e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2C18—malignant glioma	5.84e-06	3.43e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—malignant glioma	5.84e-06	3.43e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CD—malignant glioma	5.84e-06	3.43e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ASMT—malignant glioma	5.82e-06	3.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CAV1—malignant glioma	5.8e-06	3.4e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—BAD—malignant glioma	5.79e-06	3.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD80—malignant glioma	5.73e-06	3.36e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOTCH1—malignant glioma	5.73e-06	3.36e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—malignant glioma	5.73e-06	3.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT2—malignant glioma	5.73e-06	3.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—malignant glioma	5.7e-06	3.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NTRK1—malignant glioma	5.7e-06	3.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EGF—malignant glioma	5.66e-06	3.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—malignant glioma	5.66e-06	3.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTPN11—malignant glioma	5.62e-06	3.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD80—malignant glioma	5.62e-06	3.3e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.61e-06	3.29e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APC—malignant glioma	5.61e-06	3.29e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NCOR1—malignant glioma	5.56e-06	3.26e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGF—malignant glioma	5.54e-06	3.25e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NCOR1—malignant glioma	5.51e-06	3.24e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTPN11—malignant glioma	5.51e-06	3.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CD—malignant glioma	5.51e-06	3.23e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BCAN—malignant glioma	5.47e-06	3.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—BAD—malignant glioma	5.46e-06	3.2e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—BCHE—malignant glioma	5.45e-06	3.2e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.43e-06	3.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOTCH1—malignant glioma	5.4e-06	3.17e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC5A5—malignant glioma	5.38e-06	3.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP3—malignant glioma	5.3e-06	3.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD80—malignant glioma	5.29e-06	3.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APC—malignant glioma	5.28e-06	3.1e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—BRAF—malignant glioma	5.27e-06	3.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN2B—malignant glioma	5.25e-06	3.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT2—malignant glioma	5.24e-06	3.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—EGF—malignant glioma	5.22e-06	3.06e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—malignant glioma	5.21e-06	3.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTPN11—malignant glioma	5.19e-06	3.05e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CAV1—malignant glioma	5.15e-06	3.02e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT2—malignant glioma	5.13e-06	3.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTK2—malignant glioma	5.1e-06	2.99e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CB—malignant glioma	5.09e-06	2.99e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—malignant glioma	5.04e-06	2.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CD—malignant glioma	5.03e-06	2.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HES1—malignant glioma	5.01e-06	2.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—malignant glioma	5e-06	2.93e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CAV1—malignant glioma	4.99e-06	2.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NCOR1—malignant glioma	4.98e-06	2.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—BRAF—malignant glioma	4.97e-06	2.91e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CD—malignant glioma	4.93e-06	2.89e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.92e-06	2.89e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—malignant glioma	4.92e-06	2.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RAF1—malignant glioma	4.92e-06	2.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT2—malignant glioma	4.83e-06	2.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FGF2—malignant glioma	4.82e-06	2.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CB—malignant glioma	4.8e-06	2.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—malignant glioma	4.8e-06	2.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFRA—malignant glioma	4.77e-06	2.8e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.76e-06	2.79e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTT1—malignant glioma	4.72e-06	2.77e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGF2—malignant glioma	4.72e-06	2.77e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CG—malignant glioma	4.69e-06	2.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CD—malignant glioma	4.64e-06	2.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SPP1—malignant glioma	4.63e-06	2.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—malignant glioma	4.61e-06	2.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—malignant glioma	4.59e-06	2.69e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.58e-06	2.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2—malignant glioma	4.57e-06	2.68e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CG—malignant glioma	4.54e-06	2.66e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CAV1—malignant glioma	4.54e-06	2.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—malignant glioma	4.53e-06	2.66e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—malignant glioma	4.53e-06	2.66e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—malignant glioma	4.52e-06	2.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MDM2—malignant glioma	4.51e-06	2.64e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CAV1—malignant glioma	4.5e-06	2.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RAF1—malignant glioma	4.49e-06	2.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGF2—malignant glioma	4.45e-06	2.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—malignant glioma	4.44e-06	2.61e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS1—malignant glioma	4.42e-06	2.6e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MDM2—malignant glioma	4.41e-06	2.59e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—IDH2—malignant glioma	4.41e-06	2.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—malignant glioma	4.41e-06	2.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—malignant glioma	4.41e-06	2.59e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RAF1—malignant glioma	4.4e-06	2.58e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—malignant glioma	4.4e-06	2.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—malignant glioma	4.39e-06	2.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CB—malignant glioma	4.39e-06	2.57e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—malignant glioma	4.38e-06	2.57e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—malignant glioma	4.35e-06	2.55e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTP1—malignant glioma	4.34e-06	2.55e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CB—malignant glioma	4.3e-06	2.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFB—malignant glioma	4.29e-06	2.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGFR1—malignant glioma	4.26e-06	2.5e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—malignant glioma	4.26e-06	2.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—malignant glioma	4.25e-06	2.49e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAT—malignant glioma	4.22e-06	2.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HIF1A—malignant glioma	4.2e-06	2.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MDM2—malignant glioma	4.16e-06	2.44e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.15e-06	2.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—RAF1—malignant glioma	4.15e-06	2.43e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—malignant glioma	4.13e-06	2.42e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CD—malignant glioma	4.13e-06	2.42e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—BCHE—malignant glioma	4.11e-06	2.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—malignant glioma	4.1e-06	2.41e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—malignant glioma	4.09e-06	2.4e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC5A5—malignant glioma	4.06e-06	2.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CAV1—malignant glioma	4.06e-06	2.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CB—malignant glioma	4.05e-06	2.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—malignant glioma	4.04e-06	2.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—malignant glioma	4.03e-06	2.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—malignant glioma	4.02e-06	2.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—malignant glioma	4.01e-06	2.35e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CD—malignant glioma	3.99e-06	2.34e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—malignant glioma	3.99e-06	2.34e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NCOR1—malignant glioma	3.99e-06	2.34e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—malignant glioma	3.95e-06	2.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—F2—malignant glioma	3.87e-06	2.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FN1—malignant glioma	3.87e-06	2.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BAD—malignant glioma	3.82e-06	2.24e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—IDH1—malignant glioma	3.79e-06	2.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—malignant glioma	3.79e-06	2.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH1—malignant glioma	3.78e-06	2.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—malignant glioma	3.75e-06	2.2e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.74e-06	2.2e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—malignant glioma	3.71e-06	2.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CD80—malignant glioma	3.71e-06	2.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—malignant glioma	3.7e-06	2.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—malignant glioma	3.7e-06	2.17e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—malignant glioma	3.69e-06	2.17e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SPHK1—malignant glioma	3.67e-06	2.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EGF—malignant glioma	3.66e-06	2.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTPN11—malignant glioma	3.64e-06	2.13e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CD—malignant glioma	3.63e-06	2.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—malignant glioma	3.6e-06	2.11e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CD—malignant glioma	3.6e-06	2.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CB—malignant glioma	3.6e-06	2.11e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.6e-06	2.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—malignant glioma	3.56e-06	2.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—malignant glioma	3.5e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CB—malignant glioma	3.48e-06	2.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BRAF—malignant glioma	3.48e-06	2.04e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—malignant glioma	3.45e-06	2.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—malignant glioma	3.39e-06	1.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT2—malignant glioma	3.39e-06	1.99e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—malignant glioma	3.32e-06	1.95e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTP1—malignant glioma	3.27e-06	1.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CD—malignant glioma	3.25e-06	1.91e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAV1—malignant glioma	3.25e-06	1.91e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAT—malignant glioma	3.19e-06	1.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—malignant glioma	3.18e-06	1.87e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CB—malignant glioma	3.17e-06	1.86e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CB—malignant glioma	3.14e-06	1.84e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—malignant glioma	3.14e-06	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—malignant glioma	3.13e-06	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGF2—malignant glioma	3.11e-06	1.83e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—malignant glioma	3.11e-06	1.82e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—malignant glioma	3.11e-06	1.82e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—malignant glioma	3.1e-06	1.82e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—malignant glioma	3.08e-06	1.81e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—malignant glioma	3.02e-06	1.77e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NCOR1—malignant glioma	3.01e-06	1.77e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—malignant glioma	3.01e-06	1.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.96e-06	1.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—malignant glioma	2.93e-06	1.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MDM2—malignant glioma	2.91e-06	1.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—malignant glioma	2.91e-06	1.71e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTT1—malignant glioma	2.91e-06	1.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—malignant glioma	2.91e-06	1.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAF1—malignant glioma	2.9e-06	1.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—malignant glioma	2.87e-06	1.69e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—malignant glioma	2.86e-06	1.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—malignant glioma	2.85e-06	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CB—malignant glioma	2.84e-06	1.66e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—malignant glioma	2.74e-06	1.61e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS1—malignant glioma	2.73e-06	1.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—malignant glioma	2.72e-06	1.6e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—malignant glioma	2.71e-06	1.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—malignant glioma	2.69e-06	1.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—malignant glioma	2.67e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—malignant glioma	2.62e-06	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—malignant glioma	2.61e-06	1.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—malignant glioma	2.6e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.6e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BCHE—malignant glioma	2.53e-06	1.49e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—malignant glioma	2.53e-06	1.49e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.5e-06	1.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—malignant glioma	2.47e-06	1.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—malignant glioma	2.46e-06	1.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAV1—malignant glioma	2.45e-06	1.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—malignant glioma	2.45e-06	1.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—malignant glioma	2.39e-06	1.4e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.27e-06	1.33e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—malignant glioma	2.25e-06	1.32e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—malignant glioma	2.23e-06	1.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—malignant glioma	2.21e-06	1.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—malignant glioma	2.19e-06	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—malignant glioma	2.19e-06	1.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—malignant glioma	2.18e-06	1.28e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—malignant glioma	2.16e-06	1.26e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—malignant glioma	2.14e-06	1.26e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—malignant glioma	2.12e-06	1.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—malignant glioma	2.04e-06	1.19e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTP1—malignant glioma	2.02e-06	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—malignant glioma	2.02e-06	1.18e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CD—malignant glioma	1.96e-06	1.15e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAT—malignant glioma	1.96e-06	1.15e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—malignant glioma	1.96e-06	1.15e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—malignant glioma	1.93e-06	1.13e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.91e-06	1.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—malignant glioma	1.88e-06	1.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NCOR1—malignant glioma	1.85e-06	1.09e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—malignant glioma	1.79e-06	1.05e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—malignant glioma	1.73e-06	1.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—malignant glioma	1.73e-06	1.01e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CB—malignant glioma	1.71e-06	1e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—malignant glioma	1.7e-06	9.95e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—malignant glioma	1.67e-06	9.81e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—malignant glioma	1.58e-06	9.25e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—malignant glioma	1.56e-06	9.17e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAV1—malignant glioma	1.51e-06	8.86e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—malignant glioma	1.48e-06	8.68e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—malignant glioma	1.41e-06	8.28e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.38e-06	8.11e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.38e-06	8.07e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—malignant glioma	1.33e-06	7.79e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.21e-06	7.1e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—malignant glioma	1.13e-06	6.63e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.05e-06	6.19e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—malignant glioma	1.04e-06	6.13e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—malignant glioma	1.04e-06	6.12e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—malignant glioma	9.11e-07	5.35e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—malignant glioma	8.52e-07	5e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.43e-07	3.77e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—malignant glioma	5.25e-07	3.08e-06	CbGpPWpGaD
